Since launching its wildly popular weight-loss drug Wegovy in 2021, Novo Nordisk has raised its annual sales guidance several ...

Eli Lilly gains ground with Orforglipron’s success, showing growth potential and risks from momentum and tariffs. Read why ...

Prescribing of drugs between 2021 and 2023 shifted dramatically for both type 2 diabetes and weight loss for people with ...

Made in the USA, a new daily oral weight-loss pill from Eli Lilly won't require cold storage and is expected to hit markets ...

Eli Lilly, the maker of Ozempic, has developed a weight loss pill that could work as well. The new weight loss pill, ...

Orforglipron, which could become the first GLP-1 pill — a much more convenient option — is a step closer to hitting the ...

A recent medical trial could help deliver the first daily weight loss pill capable of cutting down obesity as effectively as ...

Brazil nuts, walnuts, cashews, pistachios, almonds, hazelnuts, pecans, and peanuts are calorie- and nutrient-dense additions ...

Novo Nordisk remains an industry leader, and currently offers both a 2.7% dividend yield and compelling value that can work ...

A daily pill could be as effective for weight loss as popular drugs like Wegovy and Ozempic, providing an alternative to the ...

Doctors and patients have been hoping for a pill version that would be easier to take, in contrast to an injectable.

“Medicated weight loss isn’t cheating ... Unlike in the US and New Zealand, where pharma companies can market drugs directly to consumers with certain disclosures, the UK – along with ...